Gestational diabetes & diabetes in pregnancy
Type 2 diabetes after gestational diabetes, a cross‐sectional study— DIVINE ‐ NSW
Authors' conclusion
Women consider preventing or delaying the onset of diabetes very important. Hence, studies evaluating adjunct therapies, such as pharmacotherapy, are needed to reduce their long-term risk.
Study context
- Population
- Australian women with recent (within 5 years) gestational diabetes mellitus (GDM); mean age 37.3 ± 4.9 years, body mass index (BMI) 27.5 ± 6.4 kg/m², 2.9 ± 1.4 years postpartum248 completed OGTT
- Participants
- 505 women
- Outcome
- Dysglycaemia prevalence and predictors
Methodological detailsonline questionnaire, OGTT
- Online questionnaire
- OGTT
Main finding
As reported in the abstract
Dysglycaemia prevalence (among 248 completing OGTT)
T2D
4%
Pre-diabetes
11%
Each 1 kg/m² increase in BMI: greater odds of dysglycaemia
10%
p = 0.03
Observational data: associations, not effects.
Further findings
Women's views on T2D risk and prevention
- Self-reported 5-year risk of T2D (10-point scale), median [IQR]
- 5 [3-7]
- Concern about developing T2D (10-point scale), median [IQR]
- 7 [5-9]
- Importance of preventing or delaying T2D (10-point scale), median [IQR]
- 10 [8-10]
- Likelihood of adopting lifestyle changes (out of 5), median [IQR]
- 4 [4-5]
- Likelihood of taking medication for T2D prevention (out of 5), median [IQR]
- 3 [1-4]
Original publication
Type 2 diabetes after gestational diabetes, a cross‐sectional study— DIVINE ‐ NSW. Diabet Med. Published 9 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →